ALS Limited blames human error for late director disclosure

ALS Limited reported a change in director Malcolm Deane's interests, involving the acquisition of 146,884 performance rights under the company's 2025 long-term incentive plan, valued at $2,396,926.55. These rights were granted following shareholder approval at the company's AGM on July 30, 2025. This acquisition increased Deane's total performance rights to 486,236, along with 31,454 service rights and 70,732 ordinary shares.

The company received a query from the ASX on November 4, 2025, regarding the late lodgment of an Appendix 3Y form for these performance rights. ALS confirmed that the Appendix 3Y was lodged on November 6, 2025, after the ASX query, acknowledging a human error within its corporate governance team for the delay. An Appendix 3G was also lodged late but included the shareholder-approved performance rights.

ALS Limited has procedures in place to meet disclosure obligations, which have been reviewed and updated. The company maintains that its existing arrangements are adequate and will be enforced, attributing the late lodgments to human error rather than systemic inadequacy.